• レポートコード:QYR2104Z4193 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、130ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥546,000 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥819,000 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、NSAID治療薬のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(イブプロフェン、ナプロキセン)、用途別市場規模(病院、診療所、ドラッグストア)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・NSAID治療薬の市場動向 ・企業の競争状況、市場シェア ・NSAID治療薬の種類別市場規模(イブプロフェン、ナプロキセン) ・NSAID治療薬の用途別市場規模(病院、診療所、ドラッグストア) ・NSAID治療薬の北米市場規模2016-2027(アメリカ、カナダ) ・NSAID治療薬のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・NSAID治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・NSAID治療薬の中南米市場規模2016-2027(メキシコ、ブラジル) ・NSAID治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Pfizer、GSK、Grunenthal、Bayer、Sanofi、Eli Lilly、AstraZeneca、Endo、Merck、Depomed、Yunnan Baiyao、Teva、J&J、Allergan、Purdue) ・結論 |
Market Analysis and Insights: Global NSAIDs Drug Market
The global NSAIDs Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NSAIDs Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NSAIDs Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NSAIDs Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NSAIDs Drug market.
Global NSAIDs Drug Scope and Market Size
NSAIDs Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global NSAIDs Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Ibuprofen
Naproxen
Segment by Application
Hospitals
Clinics
Drugstores
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Bayer
Sanofi
Teva
J&J
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NSAIDs Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Ibuprofen
1.2.3 Naproxen
1.3 Market by Application
1.3.1 Global NSAIDs Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstores
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global NSAIDs Drug Market Perspective (2016-2027)
2.2 NSAIDs Drug Growth Trends by Regions
2.2.1 NSAIDs Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 NSAIDs Drug Historic Market Share by Regions (2016-2021)
2.2.3 NSAIDs Drug Forecasted Market Size by Regions (2022-2027)
2.3 NSAIDs Drug Industry Dynamic
2.3.1 NSAIDs Drug Market Trends
2.3.2 NSAIDs Drug Market Drivers
2.3.3 NSAIDs Drug Market Challenges
2.3.4 NSAIDs Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NSAIDs Drug Players by Revenue
3.1.1 Global Top NSAIDs Drug Players by Revenue (2016-2021)
3.1.2 Global NSAIDs Drug Revenue Market Share by Players (2016-2021)
3.2 Global NSAIDs Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by NSAIDs Drug Revenue
3.4 Global NSAIDs Drug Market Concentration Ratio
3.4.1 Global NSAIDs Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NSAIDs Drug Revenue in 2020
3.5 NSAIDs Drug Key Players Head office and Area Served
3.6 Key Players NSAIDs Drug Product Solution and Service
3.7 Date of Enter into NSAIDs Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NSAIDs Drug Breakdown Data by Type
4.1 Global NSAIDs Drug Historic Market Size by Type (2016-2021)
4.2 Global NSAIDs Drug Forecasted Market Size by Type (2022-2027)
5 NSAIDs Drug Breakdown Data by Application
5.1 Global NSAIDs Drug Historic Market Size by Application (2016-2021)
5.2 Global NSAIDs Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America NSAIDs Drug Market Size (2016-2027)
6.2 North America NSAIDs Drug Market Size by Type
6.2.1 North America NSAIDs Drug Market Size by Type (2016-2021)
6.2.2 North America NSAIDs Drug Market Size by Type (2022-2027)
6.2.3 North America NSAIDs Drug Market Size by Type (2016-2027)
6.3 North America NSAIDs Drug Market Size by Application
6.3.1 North America NSAIDs Drug Market Size by Application (2016-2021)
6.3.2 North America NSAIDs Drug Market Size by Application (2022-2027)
6.3.3 North America NSAIDs Drug Market Size by Application (2016-2027)
6.4 North America NSAIDs Drug Market Size by Country
6.4.1 North America NSAIDs Drug Market Size by Country (2016-2021)
6.4.2 North America NSAIDs Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe NSAIDs Drug Market Size (2016-2027)
7.2 Europe NSAIDs Drug Market Size by Type
7.2.1 Europe NSAIDs Drug Market Size by Type (2016-2021)
7.2.2 Europe NSAIDs Drug Market Size by Type (2022-2027)
7.2.3 Europe NSAIDs Drug Market Size by Type (2016-2027)
7.3 Europe NSAIDs Drug Market Size by Application
7.3.1 Europe NSAIDs Drug Market Size by Application (2016-2021)
7.3.2 Europe NSAIDs Drug Market Size by Application (2022-2027)
7.3.3 Europe NSAIDs Drug Market Size by Application (2016-2027)
7.4 Europe NSAIDs Drug Market Size by Country
7.4.1 Europe NSAIDs Drug Market Size by Country (2016-2021)
7.4.2 Europe NSAIDs Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific NSAIDs Drug Market Size (2016-2027)
8.2 Asia-Pacific NSAIDs Drug Market Size by Type
8.2.1 Asia-Pacific NSAIDs Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific NSAIDs Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific NSAIDs Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific NSAIDs Drug Market Size by Application
8.3.1 Asia-Pacific NSAIDs Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific NSAIDs Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific NSAIDs Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific NSAIDs Drug Market Size by Region
8.4.1 Asia-Pacific NSAIDs Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific NSAIDs Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America NSAIDs Drug Market Size (2016-2027)
9.2 Latin America NSAIDs Drug Market Size by Type
9.2.1 Latin America NSAIDs Drug Market Size by Type (2016-2021)
9.2.2 Latin America NSAIDs Drug Market Size by Type (2022-2027)
9.2.3 Latin America NSAIDs Drug Market Size by Type (2016-2027)
9.3 Latin America NSAIDs Drug Market Size by Application
9.3.1 Latin America NSAIDs Drug Market Size by Application (2016-2021)
9.3.2 Latin America NSAIDs Drug Market Size by Application (2022-2027)
9.3.3 Latin America NSAIDs Drug Market Size by Application (2016-2027)
9.4 Latin America NSAIDs Drug Market Size by Country
9.4.1 Latin America NSAIDs Drug Market Size by Country (2016-2021)
9.4.2 Latin America NSAIDs Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NSAIDs Drug Market Size (2016-2027)
10.2 Middle East & Africa NSAIDs Drug Market Size by Type
10.2.1 Middle East & Africa NSAIDs Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa NSAIDs Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa NSAIDs Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa NSAIDs Drug Market Size by Application
10.3.1 Middle East & Africa NSAIDs Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa NSAIDs Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa NSAIDs Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa NSAIDs Drug Market Size by Country
10.4.1 Middle East & Africa NSAIDs Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa NSAIDs Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer NSAIDs Drug Introduction
11.1.4 Pfizer Revenue in NSAIDs Drug Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK NSAIDs Drug Introduction
11.2.4 GSK Revenue in NSAIDs Drug Business (2016-2021)
11.2.5 GSK Recent Development
11.3 Grunenthal
11.3.1 Grunenthal Company Details
11.3.2 Grunenthal Business Overview
11.3.3 Grunenthal NSAIDs Drug Introduction
11.3.4 Grunenthal Revenue in NSAIDs Drug Business (2016-2021)
11.3.5 Grunenthal Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer NSAIDs Drug Introduction
11.4.4 Bayer Revenue in NSAIDs Drug Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi NSAIDs Drug Introduction
11.5.4 Sanofi Revenue in NSAIDs Drug Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly NSAIDs Drug Introduction
11.6.4 Eli Lilly Revenue in NSAIDs Drug Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca NSAIDs Drug Introduction
11.7.4 AstraZeneca Revenue in NSAIDs Drug Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Endo
11.8.1 Endo Company Details
11.8.2 Endo Business Overview
11.8.3 Endo NSAIDs Drug Introduction
11.8.4 Endo Revenue in NSAIDs Drug Business (2016-2021)
11.8.5 Endo Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck NSAIDs Drug Introduction
11.9.4 Merck Revenue in NSAIDs Drug Business (2016-2021)
11.9.5 Merck Recent Development
11.10 Depomed
11.10.1 Depomed Company Details
11.10.2 Depomed Business Overview
11.10.3 Depomed NSAIDs Drug Introduction
11.10.4 Depomed Revenue in NSAIDs Drug Business (2016-2021)
11.10.5 Depomed Recent Development
11.11 Yunnan Baiyao
11.11.1 Yunnan Baiyao Company Details
11.11.2 Yunnan Baiyao Business Overview
11.11.3 Yunnan Baiyao NSAIDs Drug Introduction
11.11.4 Yunnan Baiyao Revenue in NSAIDs Drug Business (2016-2021)
11.11.5 Yunnan Baiyao Recent Development
11.12 Teva
11.12.1 Teva Company Details
11.12.2 Teva Business Overview
11.12.3 Teva NSAIDs Drug Introduction
11.12.4 Teva Revenue in NSAIDs Drug Business (2016-2021)
11.12.5 Teva Recent Development
11.13 J&J
11.13.1 J&J Company Details
11.13.2 J&J Business Overview
11.13.3 J&J NSAIDs Drug Introduction
11.13.4 J&J Revenue in NSAIDs Drug Business (2016-2021)
11.13.5 J&J Recent Development
11.14 Allergan
11.14.1 Allergan Company Details
11.14.2 Allergan Business Overview
11.14.3 Allergan NSAIDs Drug Introduction
11.14.4 Allergan Revenue in NSAIDs Drug Business (2016-2021)
11.14.5 Allergan Recent Development
11.15 Purdue
11.15.1 Purdue Company Details
11.15.2 Purdue Business Overview
11.15.3 Purdue NSAIDs Drug Introduction
11.15.4 Purdue Revenue in NSAIDs Drug Business (2016-2021)
11.15.5 Purdue Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global NSAIDs Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Ibuprofen
Table 3. Key Players of Naproxen
Table 4. Global NSAIDs Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global NSAIDs Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global NSAIDs Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global NSAIDs Drug Market Share by Regions (2016-2021)
Table 8. Global NSAIDs Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global NSAIDs Drug Market Share by Regions (2022-2027)
Table 10. NSAIDs Drug Market Trends
Table 11. NSAIDs Drug Market Drivers
Table 12. NSAIDs Drug Market Challenges
Table 13. NSAIDs Drug Market Restraints
Table 14. Global NSAIDs Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global NSAIDs Drug Market Share by Players (2016-2021)
Table 16. Global Top NSAIDs Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NSAIDs Drug as of 2020)
Table 17. Ranking of Global Top NSAIDs Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by NSAIDs Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players NSAIDs Drug Product Solution and Service
Table 21. Date of Enter into NSAIDs Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global NSAIDs Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global NSAIDs Drug Revenue Market Share by Type (2016-2021)
Table 25. Global NSAIDs Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global NSAIDs Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global NSAIDs Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global NSAIDs Drug Revenue Market Share by Application (2016-2021)
Table 29. Global NSAIDs Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global NSAIDs Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America NSAIDs Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America NSAIDs Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America NSAIDs Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America NSAIDs Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America NSAIDs Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America NSAIDs Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe NSAIDs Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe NSAIDs Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe NSAIDs Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe NSAIDs Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe NSAIDs Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe NSAIDs Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific NSAIDs Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific NSAIDs Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific NSAIDs Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific NSAIDs Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific NSAIDs Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific NSAIDs Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America NSAIDs Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America NSAIDs Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America NSAIDs Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America NSAIDs Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America NSAIDs Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America NSAIDs Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa NSAIDs Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa NSAIDs Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa NSAIDs Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa NSAIDs Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa NSAIDs Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa NSAIDs Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer NSAIDs Drug Product
Table 64. Pfizer Revenue in NSAIDs Drug Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. GSK Company Details
Table 67. GSK Business Overview
Table 68. GSK NSAIDs Drug Product
Table 69. GSK Revenue in NSAIDs Drug Business (2016-2021) & (US$ Million)
Table 70. GSK Recent Development
Table 71. Grunenthal Company Details
Table 72. Grunenthal Business Overview
Table 73. Grunenthal NSAIDs Drug Product
Table 74. Grunenthal Revenue in NSAIDs Drug Business (2016-2021) & (US$ Million)
Table 75. Grunenthal Recent Development
Table 76. Bayer Company Details
Table 77. Bayer Business Overview
Table 78. Bayer NSAIDs Drug Product
Table 79. Bayer Revenue in NSAIDs Drug Business (2016-2021) & (US$ Million)
Table 80. Bayer Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi NSAIDs Drug Product
Table 84. Sanofi Revenue in NSAIDs Drug Business (2016-2021) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. Eli Lilly Company Details
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly NSAIDs Drug Product
Table 89. Eli Lilly Revenue in NSAIDs Drug Business (2016-2021) & (US$ Million)
Table 90. Eli Lilly Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca NSAIDs Drug Product
Table 94. AstraZeneca Revenue in NSAIDs Drug Business (2016-2021) & (US$ Million)
Table 95. AstraZeneca Recent Development
Table 96. Endo Company Details
Table 97. Endo Business Overview
Table 98. Endo Revenue in NSAIDs Drug Business (2016-2021) & (US$ Million)
Table 99. Endo Recent Development
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck NSAIDs Drug Product
Table 103. Merck Revenue in NSAIDs Drug Business (2016-2021) & (US$ Million)
Table 104. Merck Recent Development
Table 105. Depomed Company Details
Table 106. Depomed Business Overview
Table 107. Depomed NSAIDs Drug Product
Table 108. Depomed Revenue in NSAIDs Drug Business (2016-2021) & (US$ Million)
Table 109. Depomed Recent Development
Table 110. Yunnan Baiyao Company Details
Table 111. Yunnan Baiyao Business Overview
Table 112. Yunnan Baiyao NSAIDs Drug Product
Table 113. Yunnan Baiyao Revenue in NSAIDs Drug Business (2016-2021) & (US$ Million)
Table 114. Yunnan Baiyao Recent Development
Table 115. Teva Company Details
Table 116. Teva Business Overview
Table 117. Teva NSAIDs Drug Product
Table 118. Teva Revenue in NSAIDs Drug Business (2016-2021) & (US$ Million)
Table 119. Teva Recent Development
Table 120. J&J Company Details
Table 121. J&J Business Overview
Table 122. J&J NSAIDs Drug Product
Table 123. J&J Revenue in NSAIDs Drug Business (2016-2021) & (US$ Million)
Table 124. J&J Recent Development
Table 125. Allergan Company Details
Table 126. Allergan Business Overview
Table 127. Allergan NSAIDs Drug Product
Table 128. Allergan Revenue in NSAIDs Drug Business (2016-2021) & (US$ Million)
Table 129. Allergan Recent Development
Table 130. Purdue Company Details
Table 131. Purdue Business Overview
Table 132. Purdue NSAIDs Drug Product
Table 133. Purdue Revenue in NSAIDs Drug Business (2016-2021) & (US$ Million)
Table 134. Purdue Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NSAIDs Drug Market Share by Type: 2020 VS 2027
Figure 2. Ibuprofen Features
Figure 3. Naproxen Features
Figure 4. Global NSAIDs Drug Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Drugstores Case Studies
Figure 8. NSAIDs Drug Report Years Considered
Figure 9. Global NSAIDs Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global NSAIDs Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global NSAIDs Drug Market Share by Regions: 2020 VS 2027
Figure 12. Global NSAIDs Drug Market Share by Regions (2022-2027)
Figure 13. Global NSAIDs Drug Market Share by Players in 2020
Figure 14. Global Top NSAIDs Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NSAIDs Drug as of 2020
Figure 15. The Top 10 and 5 Players Market Share by NSAIDs Drug Revenue in 2020
Figure 16. Global NSAIDs Drug Revenue Market Share by Type (2016-2021)
Figure 17. Global NSAIDs Drug Revenue Market Share by Type (2022-2027)
Figure 18. North America NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America NSAIDs Drug Market Share by Type (2016-2027)
Figure 20. North America NSAIDs Drug Market Share by Application (2016-2027)
Figure 21. North America NSAIDs Drug Market Share by Country (2016-2027)
Figure 22. United States NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe NSAIDs Drug Market Share by Type (2016-2027)
Figure 26. Europe NSAIDs Drug Market Share by Application (2016-2027)
Figure 27. Europe NSAIDs Drug Market Share by Country (2016-2027)
Figure 28. Germany NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific NSAIDs Drug Market Share by Type (2016-2027)
Figure 36. Asia-Pacific NSAIDs Drug Market Share by Application (2016-2027)
Figure 37. Asia-Pacific NSAIDs Drug Market Share by Region (2016-2027)
Figure 38. China NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America NSAIDs Drug Market Share by Type (2016-2027)
Figure 46. Latin America NSAIDs Drug Market Share by Application (2016-2027)
Figure 47. Latin America NSAIDs Drug Market Share by Country (2016-2027)
Figure 48. Mexico NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa NSAIDs Drug Market Share by Type (2016-2027)
Figure 52. Middle East & Africa NSAIDs Drug Market Share by Application (2016-2027)
Figure 53. Middle East & Africa NSAIDs Drug Market Share by Country (2016-2027)
Figure 54. Turkey NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE NSAIDs Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in NSAIDs Drug Business (2016-2021)
Figure 58. GSK Revenue Growth Rate in NSAIDs Drug Business (2016-2021)
Figure 59. Grunenthal Revenue Growth Rate in NSAIDs Drug Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in NSAIDs Drug Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in NSAIDs Drug Business (2016-2021)
Figure 62. Eli Lilly Revenue Growth Rate in NSAIDs Drug Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in NSAIDs Drug Business (2016-2021)
Figure 64. Endo Revenue Growth Rate in NSAIDs Drug Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in NSAIDs Drug Business (2016-2021)
Figure 66. Depomed Revenue Growth Rate in NSAIDs Drug Business (2016-2021)
Figure 67. Yunnan Baiyao Revenue Growth Rate in NSAIDs Drug Business (2016-2021)
Figure 68. Teva Revenue Growth Rate in NSAIDs Drug Business (2016-2021)
Figure 69. J&J Revenue Growth Rate in NSAIDs Drug Business (2016-2021)
Figure 70. Allergan Revenue Growth Rate in NSAIDs Drug Business (2016-2021)
Figure 71. Purdue Revenue Growth Rate in NSAIDs Drug Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed